GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2026)

GE HealthCare Technologies' Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

• Quarterly Current Deferred Revenue rose 13.74% year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 billion (up 13.74% YoY) and the FY2025 annual result came in at $2.1 billion, up 7.82% from the prior year.
• Current Deferred Revenue was $3.0 billion for Q1 2026 at GE HealthCare Technologies, up from $2.1 billion in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $3.0 billion in Q1 2026 and bottomed at $1.9 billion in Q1 2024.
• A 5-year average of $2.2 billion and a median of $2.0 billion in 2023 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2024 — Current Deferred Revenue retreated 26.63% — and 2025, when it jumped 39.06%.
• GE HealthCare Technologies' Current Deferred Revenue stood at $2.5 billion in 2022, then decreased by 24.07% to $1.9 billion in 2023, then advanced by 1.3% to $1.9 billion in 2024, then climbed by 7.82% to $2.1 billion in 2025, then jumped by 41.86% to $3.0 billion in 2026.
• Business Quant data shows GEHC's Current Deferred Revenue at $3.0 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.0 billion in Q3 2025.